Proactive Investors - Run By Investors For Investors

'Interest is growing exponentially', says Oxford Biodynamics' Christian Hoyer Millar

Oxford Biodynamics (LON:OBD) CEO Christian Hoyer Millar and CSO Sasha Akoulitchev talk to Proactive's Andrew Scott about the company's platform EpiSwitch as well as the overall strategy and outlook.

Their technology manages biomarkers in people’s blood to help pharmaceutical companies identify which patients will react to certain drugs.

''We've worked with six of the biggest pharma and biotech companies in the world so far. We've undertaken about 23 projects and the interest in what we're doing is growing exponentially'', Hoyer Millar says.

 
Meet Alliance Pharma PLC, IXICO PLC, Benchmark Holdings PLC, Clinigen Group PLC and Shield Therapeutics PLC at our event, London , 24 January 2019. Register here »
View full OBD profile View Profile

Oxford Biodynamics PLC Timeline

© Proactive Investors 2019

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use